# A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers

> **NCT03411421** · PHASE1 · TERMINATED · sponsor: **Alios Biopharma Inc.** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AL-794
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03411421
- **Lead sponsor:** Alios Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-03
- **Primary completion:** 2018-04-27
- **Final completion:** 2018-04-27
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** The study was closed as the data received to date did not support continuation of the study.
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03411421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03411421, "A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03411421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*